Client:
BioSynthetix
BioSynthetix IP Fortification
Client:
BioSynthetix
BioSynthetix IP Fortification
Client:
BioSynthetix
BioSynthetix IP Fortification
The Overview
Defending a core CRISPR-related patent portfolio against international challenges.
The Architecture
We implemented a 'Defensive Mesh' strategy, cross-licensing critical non-core patents to competitors to prevent long-term litigation cycles.
Structural Impact
Portfolio secured with an estimated value increase of $400M prior to the IPO.
The Overview
Defending a core CRISPR-related patent portfolio against international challenges.
The Architecture
We implemented a 'Defensive Mesh' strategy, cross-licensing critical non-core patents to competitors to prevent long-term litigation cycles.
Structural Impact
Portfolio secured with an estimated value increase of $400M prior to the IPO.
The Overview
Defending a core CRISPR-related patent portfolio against international challenges.
The Architecture
We implemented a 'Defensive Mesh' strategy, cross-licensing critical non-core patents to competitors to prevent long-term litigation cycles.
Structural Impact
Portfolio secured with an estimated value increase of $400M prior to the IPO.